Inhibiting HMGB1 decreased the expression of distinct immune response-related genes, particularly those regulated by NF-kB signaling, affirming that HMGB1 is a critical mediator in the communication between lung cancer cells and the immune system. Here, NFKB1 is linked to lung carcinoma.